ABSTRACT
Cardiovascular benefits for the general population of combined aerobic-resistance exercise training are well-known, but the impact of this exercise training modality on the plasma lipid, inflammatory, and antioxidant status in elderly women that are exposed to a great risk of developing ischemic cardio- and cerebrovascular diseases has not been well investigated. So, we aimed to evaluate the plasma lipids, oxidative stress, and inflammatory cytokines in 27 elderly women (TRAINED group, 69.1 ± 8.1 yrs) that were performing moderate intensity combined aerobic-resistance exercise training (3 times/week for at least 18 months) and in 27 sedentary elderly women (SED group, 72.0 ± 6.4 yrs), not submitted to exercise training for at least 5 yrs. Our results showed that BMI was lower in the TRAINED group than in the SED group (25.1 ± 3.2 vs. 28.7 ± 5.1, p < 0.05). The TRAINED group had lower glycemia (92 ± 3 vs. 118 ± 12, p < 0.05), glycated hemoglobin (5.9 ± 0.1 vs. 6.4 ± 0.2, p < 0.05), and triglycerides (98 (75-122) vs. 139 (109-214), p < 0.01); equal total cholesterol (199 (175-230) vs. 194 (165-220)), LDL-cholesterol (108 (83-133) vs. 109 (98-136)), and non-HDL-cholesterol (54 (30-74) vs. 62 (26-80)); and also higher HDL-cholesterol (64 (52-77) vs. 52 (44-63), p < 0.01) and LDL-C/oxLDL ratio (13378 ± 2570 vs. 11639 ± 3113, p < 0.05) compared to the SED group. Proinflammatory cytokines as IL-1ß (11.31 ± 2.4 vs. 28.01 ± 4.7, p < 0.05), IL-6 (26.25 ± 7.4 vs. 49.41 ± 17.8, p < 0.05), and TNF-α (25.72 ± 2.8 vs. 51.73 ± 4.2, p < 0.05) were lower in the TRAINED group than in the SED group. The TRAINED group had lower total peroxides (26.3 ± 7.4 vs. 49.0 ± 17.8, p < 0.05) and oxidized LDL (1551 ± 50.33 vs. 1773 ± 74, p < 0.02) and higher total antioxidant capacity (26.25 ± 7.4 vs. 49.41 ± 17.8, p < 0.001) compared to the SED group. In conclusion, in TRAINED women, BMI was lower, plasma lipid profile was better, plasma oxidative stress was diminished, and there was less expression of proinflammatory interleukins than in SED, suggesting that combined aerobic-resistance exercise training may promote the protection against the complications of ischemic cardio- and cerebrovascular disease in elderly women.
Subject(s)
Cerebrovascular Disorders , Cytokines/blood , Exercise , Lipids/blood , Oxidative Stress , Aged , Aged, 80 and over , Cerebrovascular Disorders/blood , Cerebrovascular Disorders/prevention & control , Female , Humans , Middle Aged , Oxidation-Reduction , Time FactorsABSTRACT
INTRODUCTION: Cerebrovascular disease (CVD) and cancer are among the most common causes of mortality worldwide, preceded only by ischemic heart disease (IHD). Thrombocytopenia was shown to be associated with poor outcomes in IHD and CVD in the general population. This study aimed to assess the relationship of thrombocytopenia with poor outcomes in cancer patients with CVD. MATERIALS AND METHODS: Data on patients with concomitant CVD and cancer who were initially treated at a cancer referral center between January 2010 and December 2017 were included. Thrombocytopenia was defined as a platelet count < 150,000/mm3 during the first 24 h of CVD symptom onset. The IRB (CI/837/17) approved the review of clinical records. RESULTS: Among 268 cancer patients with CVD included in the study, 210 met the inclusion criteria. Median overall survival of the entire cohort was 7.2 months, which was significantly shorter in males (p = 0.029) and patients with hematologic tumors (p = 0.009), hemorrhagic CVD (p < 0.001), altered mental status (p < 0.001), and thrombocytopenia (p < 0.001). Multiple regression logistic analysis revealed that thrombocytopenia (risk ratio [RR] 1.6, 95% confidence interval [CI] 1.1-2.4) and altered mental status (RR 2.7, 95% CI 1.9-4.0) remained statistically significant risk factors for mortality. CONCLUSION: In cancer patients with CVD, thrombocytopenia at the time of CVD diagnosis and altered mental status during initial clinical evaluation were associated with higher mortality, which should be confirmed in future studies.
Subject(s)
Cerebrovascular Disorders/complications , Neoplasms/blood , Neoplasms/diagnosis , Stroke/complications , Thrombocytopenia/complications , Cerebrovascular Disorders/blood , Cerebrovascular Disorders/epidemiology , Female , Humans , Kaplan-Meier Estimate , Male , Middle Aged , Neoplasms/epidemiology , Odds Ratio , Platelet Count , Prognosis , Prospective Studies , Risk Factors , Stroke/blood , Stroke/epidemiology , Thrombocytopenia/epidemiologyABSTRACT
OBJECTIVE: To investigate the neuropsychological characteristics and changes in CRP, S100B, MBP, HSP-7, and NSE in serum. METHOD: Sixty-six (66) patients treated in our hospital as CCCI group were chosen for our study, and 90 patients with depression were selected as the depression group. The patients in both groups were examined with CT perfusion, depression, anxiety and cognition evaluation. Their serum CRP, S100B, MBP, HSP-70 and NSE levels were detected. Neuropsychological and serum markers characteristics were compared. RESULTS: The CBF and CBV in bilateral basal ganglia, frontal lobes, greater oval center, brain stem, and left and right regions of occipital lobes of the patients in CCCI group were significantly lower than in the depression group. The HAMD and HAMA scores of CCCI group patients were significantly lower than in the depression group; CCCI group performed better regarding attention, memory, abstract terms and delayed recall. CCCI also had significantly higher total scores than the depression group. Serum CRP, S100B, MBP, HSP-70 and NSE levels in CCCI group were significantly higher than in the depression group. The differences reach statistical significance (p<0.05). CONCLUSION: CCCI patients who are accompanied by minor depressive disorder have different degrees of cognitive impairment and experience a significant rise in serum CRP, S100B, MBP, HSP-70 and NSE.
Subject(s)
Anxiety/diagnosis , Biomarkers/blood , Cerebrovascular Circulation/physiology , Cerebrovascular Disorders/blood , Depressive Disorder/diagnosis , Aged , C-Reactive Protein/analysis , Cerebrovascular Disorders/diagnosis , Cerebrovascular Disorders/physiopathology , Chronic Disease , Female , HSP70 Heat-Shock Proteins/blood , Humans , Male , Middle Aged , Myelin Basic Protein/blood , Neuropsychological Tests , Phosphopyruvate Hydratase/blood , Polymerase Chain Reaction , Risk Factors , S100 Calcium Binding Protein beta Subunit/blood , Tomography, X-Ray ComputedABSTRACT
Summary Objective: To investigate the neuropsychological characteristics and changes in CRP, S100B, MBP, HSP-7, and NSE in serum. Method: Sixty-six (66) patients treated in our hospital as CCCI group were chosen for our study, and 90 patients with depression were selected as the depression group. The patients in both groups were examined with CT perfusion, depression, anxiety and cognition evaluation. Their serum CRP, S100B, MBP, HSP-70 and NSE levels were detected. Neuropsychological and serum markers characteristics were compared. Results: The CBF and CBV in bilateral basal ganglia, frontal lobes, greater oval center, brain stem, and left and right regions of occipital lobes of the patients in CCCI group were significantly lower than in the depression group. The HAMD and HAMA scores of CCCI group patients were significantly lower than in the depression group; CCCI group performed better regarding attention, memory, abstract terms and delayed recall. CCCI also had significantly higher total scores than the depression group. Serum CRP, S100B, MBP, HSP-70 and NSE levels in CCCI group were significantly higher than in the depression group. The differences reach statistical significance (p<0.05). Conclusion: CCCI patients who are accompanied by minor depressive disorder have different degrees of cognitive impairment and experience a significant rise in serum CRP, S100B, MBP, HSP-70 and NSE.
Subject(s)
Humans , Male , Female , Aged , Anxiety/diagnosis , Biomarkers/blood , Cerebrovascular Circulation/physiology , Cerebrovascular Disorders/blood , Depressive Disorder/diagnosis , Phosphopyruvate Hydratase/blood , C-Reactive Protein/analysis , Tomography, X-Ray Computed , Cerebrovascular Disorders/diagnosis , Cerebrovascular Disorders/physiopathology , Polymerase Chain Reaction , Chronic Disease , Risk Factors , HSP70 Heat-Shock Proteins/blood , Myelin Basic Protein/blood , S100 Calcium Binding Protein beta Subunit/blood , Middle Aged , Neuropsychological TestsABSTRACT
All studies attempting to find an association between vitamin D deficiency and cerebrovascular diseases have been conducted at latitudes far away from the Equator, where living conditions, cardiovascular risk factors, and sunshine exposure are different from tropical regions. We aimed to assess cerebrovascular correlates of vitamin D deficiency in community-dwelling older adults living in Atahualpa, a village located in rural coastal Ecuador. Out of 267 individuals enrolled in the neuroimaging substudy of the Atahualpa Project, 220 (82%) signed the informed consent. Mean age of participants was 70·9 ± 7·8 years, and 126 (57%) were women. Fifty-four (25%) persons have vitamin D levels <20 ng/ml, 47 (21%) had ischemic strokes, and 53 (24%) had moderate-to-severe white matter hyperintensities of presumed vascular origin. Exposure effect models constructed with vitamin D deficiency as the exposure, white matter hyperintensities and ischemic stroke as the outcomes, and confounders--age, gender, body mass index, physical activity, blood pressure, fasting glucose, total cholesterol, ionized calcium, phosphorus, intact parathormone, and serum creatinine--as independent variables revealed a significant association of vitamin D deficiency with white matter hyperintensities (P = 0·006) but not with ischemic strokes (P = 0·359). This study shows an association of vitamin D deficiency with diffuse subcortical brain damage in older adults living in a tropical region. Lack of awareness of the importance of vitamin D deficiency might be one of the factors influencing the high prevalence of white matter hyperintensities of presumed vascular origin in underserved Latin American populations.
Subject(s)
Cerebrovascular Disorders/epidemiology , Cerebrovascular Disorders/pathology , Vitamin D Deficiency/epidemiology , Vitamin D Deficiency/pathology , Aged , Blood Chemical Analysis , Brain/pathology , Cerebrovascular Disorders/blood , Ecuador/epidemiology , Female , Humans , Male , Rural Population , Sex Factors , Vitamin D/blood , Vitamin D Deficiency/blood , White Matter/pathologyABSTRACT
Polymorphisms in the apolipoprotein-E (apoE) gene may modulate lipoprotein metabolism at different steps and influence total and low density lipoprotein (LDL) cholesterol (LDLc) levels, as well as other lipid features. Population studies have documented significant differences in the frequency of apoE alleles which are related to the prevalence of various cardio-vascular and neuro-psychiatric diseases. In this study, the apoE genotypes and allele frequencies were analyzed in 216 individuals (109 dyslipidemic and 107 normo-lipidic subjects), and the relative contribution of apoE polymorphism on plasma lipid and lipoprotein levels, as well as risk factors was evaluated. In normo-lipidic volunteers, the frequencies of epsilon2, epsilon3 and epsilon4 alleles were 0.042, 0.832 and 0.126, while in dyslipidemic subjects 0.046, 0.835 and 0.119, respectively. No significant difference was observed among epsilon2, epsilon3 or epsilon4 and plasma lipid-lipoprotein levels in the dyslipidemic group. In normo-lipidemics, however, total cholesterol, LDLc and non-HDLc plasma levels were significantly lower in epsilon2 subjects when compared to epsilon3 and epsilon4 individuals. The allelic frequencies of apoE epsilon2, epsilon3 and epsilon4 were similar in dyslipidemic and normo-lipemic subjects, suggesting that apoE polymorphisms have no effect on plasma lipid-lipoprotein levels in dyslipidemic subjects. In contrast, in normo-lipemic subjects the epsilon2 allele showed to be associated with lower total cholesterol and LDLc levels, the mark of a better lipid profile. Depending on other co-existing factors, the epsilon2 allele, therefore, may play either a protective or pathogenic role. This elementary knowledge is a fundamental prerequisite for a possible diagnostic application of these lipoproteins as biomarkers to predict adverse cardio-vascular and/or neuro-psychiatric maladies.
Subject(s)
Apolipoproteins E/genetics , Dyslipidemias/blood , Dyslipidemias/genetics , Genetic Predisposition to Disease/genetics , Lipids/blood , Polymorphism, Genetic/genetics , Adult , Apolipoprotein E2/genetics , Apolipoprotein E3/genetics , Apolipoprotein E4/genetics , Cardiovascular Diseases/blood , Cardiovascular Diseases/genetics , Cardiovascular Diseases/physiopathology , Cerebrovascular Disorders/blood , Cerebrovascular Disorders/genetics , Cerebrovascular Disorders/physiopathology , Cholesterol, LDL/analysis , Cholesterol, LDL/blood , DNA Mutational Analysis , Dyslipidemias/complications , Female , Gene Frequency/genetics , Genetic Testing , Genotype , Humans , Lipids/analysis , Lipoproteins/analysis , Lipoproteins/blood , Male , Middle Aged , Reference Values , Risk FactorsABSTRACT
El implante percutáneo del stent carotídeo es utilizado ampliamente en todo el mundo como una alternativa menos invasiva a la endarterectomía carotídea para la prevención del ataque cerebrovascular isquémico causada por una estemosis arterial carotídea extracraneana. La estenosis arterial carotídea que particularmente involucra el origen de la arteria carótidea interna, es un problema clínico frecuente. Esta estenosis de etiología invariablemente aterosclerótica, puede presentarse como un soplo carotídeo asintomático descubierto en el examen físico, o por ataques isquémicos transitorios relacionados con la embolización de trombos originados en el sitio de lesión, o menos comúnmente como un ataque isquémico cerebral. Recientes estudios observacionales y aleatorizados han demostrado que el riesgo de sufrir un accidente cerebrovascular o muerte relacionado con el implante de stent carotídeo es comparable a endarterectomía carotídea, cuando operadores entrenados realizan estas intervenciones en grupos de pacientes bien definidos.
Carotid artery stenting is now utilized worlwide as a less invasive alternative to carotid end arterectomy for the prevention of ischemic strokes caused by stenoses at the extracraneal bifurcation of carotid arteries. Carotid artery stenosis, particularly involving the origin of the internal carotid artery, is a frequently encountered clinical problem. Such stenoses, almost invariably atherosclerotic, can present as an asymptomatic bruit discovered on physical examination, asone or more transient ischemic attacks related to embolization from a stenotic lesion or less commonly, as an ischemic stroke. Recent observational and randomized studies have shown that the risk of procedure-related stroke and death is comparable with carotid endarterectomy when skilled operators perform these interventions in well-defined patient subsets.
Subject(s)
Humans , Aorta, Thoracic/anatomy & histology , Endarterectomy, Carotid/methods , Cerebrovascular Disorders/pathology , Cerebrovascular Disorders/blood , Angioplasty/methods , Prostheses and Implants , Protective Devices , VenezuelaABSTRACT
BACKGROUND: Carotid intraplaque hemorrhage is a marker of atheroma instability. Noninvasive assessment of bleeding can be performed by high-resolution magnetic resonance imaging (MRI), but its association with inflammatory markers has not been clearly demonstrated. METHODS: We evaluated consecutive carotid endarterectomy patients that underwent high-resolution MRI, independent evaluation of neurologic symptoms, C-reactive protein measurement, and histologic analysis. Intraplaque hemorrhage was determined by the presence of a hyperintense MRI signal (T1-weighted sequence). RESULTS: The study included 70 predominantly male (66%) and hypertensive (89%) patients (89%) aged 66 +/- 9 years old. MR angiography identified 15 patients (21.5%) with stenosis between 50% and 69%, 15 (21.5%) with stenosis between 70% and 90%, and 40 (57%) with stenosis >90%. High-resolution MRI depicted a hyperintense signal suggestive of intraplaque bleeding in 45 subjects (64%). All patients who had had transient ischemic attacks >90 days before the surgery showed a hyperintense signal on MRI (P = .007). Age, gender, traditional cardiovascular risk factors, and history of myocardial infarction or peripheral arterial disease were similar in patients with or without signs of intraplaque bleeding on MRI. There was excellent agreement between acute or recent hemorrhage on histologic and MRI findings (kappa coefficient, 0.91; 95% confidence interval, 0.81 to 1.00). Only one of 45 patients (2%) with a hyperintense signal on MRI did not have acute or recent hemorrhage in the histologic analysis (P < .001). High-sensitivity C-reactive protein levels were similar for different degrees of carotid stenosis as assessed by MR angiography, but they were significantly higher in clinically unstable patients (P = .006) and in those with a positive hyperintense MRI signal (P = .01). In an aggregated analysis of neurologic symptoms and MRI findings, we found a progressive increase of high-sensitivity C-reactive protein levels (P = .02). CONCLUSIONS: Intraplaque hemorrhage evaluated by MRI identified neurologically unstable patients with increased levels of high-sensitivity C-reactive protein regardless of the degree of carotid stenosis.
Subject(s)
C-Reactive Protein/metabolism , Carotid Stenosis/complications , Cerebrovascular Disorders/etiology , Hemorrhage/pathology , Magnetic Resonance Angiography , Aged , Biomarkers/blood , Carotid Stenosis/blood , Carotid Stenosis/pathology , Carotid Stenosis/surgery , Cerebrovascular Disorders/blood , Cerebrovascular Disorders/pathology , Cerebrovascular Disorders/surgery , Endarterectomy, Carotid , Female , Hemorrhage/blood , Hemorrhage/etiology , Hemorrhage/surgery , Humans , Male , Middle Aged , Predictive Value of Tests , Prospective Studies , Risk Factors , Sensitivity and Specificity , Severity of Illness IndexABSTRACT
Trypanosoma cruzi infection is a common cause of cardiopathy in South America leading it eventually to an established stroke; however, the association between T. cruzi infection itself and cerebrovascular disease is still unknown. We did a case-control study at Eastern Colombia and found that T. cruzi infection was more frequent and statistically significant in stroke cases (24.4%) than controls (1.9%), (Chi square: 21.72; OR: 16.13; 95% confidence interval (CI): 3.64-71.4; p<0.00001). After removing the seropositive patients with cardiological abnormalities, the significance still remained by multivariate analysis (p<0.05). This is the first case-control study that demonstrated a significant link between this infection and symptomatic cerebrovascular disease, mainly ischemic, regardless of cardiac abnormalities. Therefore, we recommend that patients with stroke must be screened for T. cruzi infection if they currently live or have lived in places where this parasite is considered endemic.
Subject(s)
Cerebrovascular Disorders/parasitology , Chagas Disease , Stroke/parasitology , Trypanosoma cruzi/isolation & purification , Age Factors , Aged , Aged, 80 and over , Animals , Case-Control Studies , Cerebrovascular Disorders/blood , Cerebrovascular Disorders/epidemiology , Chagas Disease/complications , Chagas Disease/epidemiology , Chagas Disease/virology , Colombia/epidemiology , Confidence Intervals , Female , Humans , Male , Middle Aged , Multivariate Analysis , Risk Factors , Sex Factors , Stroke/blood , Stroke/epidemiologyABSTRACT
El conocimiento de los factores de riesgo cardiovascular ha permitido identificar mejor a aquellos pacientes con mayor riesgo de infarto agudo del miocardio o accidentes vasculares cerebrales. Sin embargo existe un porcentaje de pacientes que , aun sufriendo estos eventos, al ser estudiados no se les encuentra ningún factor de riesgo conocido. Últimamente se le ha dado mayor importancia a la reología sanguínea, siendo la viscosidad sanguínea la principal. Se revisan conceptos fisiopatológicos, evidencia experimental, estudios clínicos y poblacionales que dan soporte para postitular que el estudio de la viscosidad sanguínea debiera hacerse en pacientes con alto riesgo.
Subject(s)
Blood Viscosity , Cardiovascular Diseases/prevention & control , Cardiovascular Diseases/blood , Erythrocyte Aggregation , Fibrinogen/analysis , Hypertension/etiology , Myocardial Infarction/etiology , Myocardial Infarction/blood , Platelet Aggregation Inhibitors/therapeutic use , Risk Factors , Cerebrovascular Disorders/etiology , Cerebrovascular Disorders/bloodABSTRACT
Serum cholesteryl ester transfer protein (CETP) concentration was measured in 1128 healthy Chinese subjects using a "sandwich" enzyme immunoassay and was 1.84 +/- 1.55 mg/l (mean +/- S.D.). The frequency distribution of CETP in healthy subjects was markedly skewed towards low concentrations. The CETP concentration in females was significantly higher than that in males (2.40 +/- 1.65 mg/l vs. 1.49 +/- 1.37 mg/l, P < 0.001). There was a weak inverse correlation between the CETP concentration and age (r = -0.19, P < 0.001). The CETP concentrations were significantly higher in 117 myocardial infarction (MI) survivors and 110 stroke patients than that in 335 healthy, age-matched males (1.98 +/- 1.68 173 +/- 1.45, and 1.40 +/- 1.37 mg/l respectively, P < 0.01), while no relation was found between CETP concentration and lipids concentration in MI, stroke and healthy group.
Subject(s)
Cardiovascular Diseases/blood , Carrier Proteins/blood , Cerebrovascular Disorders/blood , Glycoproteins , Cardiovascular Diseases/ethnology , Case-Control Studies , Cerebrovascular Disorders/ethnology , China , Cholesterol Ester Transfer Proteins , Female , Humans , Lipids/blood , MaleSubject(s)
Cardiovascular Diseases/epidemiology , Endothelium, Vascular/physiopathology , Homocysteine/blood , Amino Acid Metabolism, Inborn Errors/blood , Amino Acid Metabolism, Inborn Errors/genetics , Amino Acid Metabolism, Inborn Errors/physiopathology , Avitaminosis/complications , Cardiovascular Diseases/blood , Cerebrovascular Disorders/blood , Cerebrovascular Disorders/etiology , Homocysteine/metabolism , Homocystinuria/blood , Homocystinuria/complications , Homozygote , Humans , Methionine/metabolism , Myocardial Ischemia/epidemiology , Myocardial Ischemia/etiology , Peripheral Vascular Diseases/blood , Peripheral Vascular Diseases/etiology , Risk Factors , Thrombophlebitis/blood , Thrombophlebitis/etiology , Vitamins/therapeutic useABSTRACT
No protocolo de avaliaçäo clínico-laboratorial de pacientes com acidente vascular cerebral (AVC) aterotrombótico dosamos e analisamos níveis de fibrinogênio plasmático (técnica de Clauss automatizada), para determinar seu possível papel como fator de risco trombogênico em 29 pacientes (20 homens e 9 mulheres) com idades entre 25 a 79 anos (mediana=55); todos tinham tido AVC aterotrombótico. Eles foram classificados em 2 grupos segundo alteraçöes de fluxo nas carótidas: g1 - sem alteraçäo de fluxo (n=19) e g2 - com alteraçöes de fluxo (n=10). Resultados- A média das dosagens de fibrinogênio no g1 foi de 269 e no g2 de 353 mg/dl. Quarenta e sete por cento dos pacientes do g1 e 80 por cento do g2, apresentaram medidas >300 mg/dl. As diferenças obtidas entre os grupos neste estudo foram significante. Conclusäo- Considerando o nível de risco epidemiológico de 300 mg/dl, nossos resultados sugerem que o fibrinogênio é um fator de risco independente para AVC aterotrombótico, especialmente naqueles com alteraçäo de fluxo carotídeo.
Subject(s)
Female , Humans , Aged , Middle Aged , Adult , Cerebrovascular Disorders , Fibrinogen/analysis , Risk Factors , Brain Ischemia/blood , Cerebrovascular Disorders/blood , Fibrinogen/physiology , Intracranial Embolism and Thrombosis/blood , Statistics, NonparametricABSTRACT
Oxygen saturation was determined by pulse oximetry in a representative sample of Jamaican patients with steady-state sickle cell disease in a cohort study from birth. There were 220 with homozygous sickle cell (SS) disease and 142 with sickle cell-haemoglobin C (SC) disease aged 9-18 years, and 122 with a normal haemoglobin (AA) genotype aged 15-18 years. Pulse oximetry (SpO2) values were lower in SS disease (mean [95% confidence interval], 92.5 [92.0-93.0]) than in SC disease (96.7[96.5-96.9]) or AA controls (97.1 [96.8-97.3]). Inhalation of 100% oxygen in SS patients with O2 saturations below 90% consistently increased saturation to 99-100%. In SS disease, SpO2 correlated positively with haemoglobin and fetal haemoglobin and negatively with reticulocyte counts but not with MCHC, MCV or bilirubin level. Mean SpO2 in SS subjects with a normal alpha globin gene complement (mean [SD], 91.7 [3.9]%) was lower than in heterozygotes (93.4 [4.0]%) or homozygotes (96.1 [3.0]%) for alpha+ thalassaemia, the effects of alpha-thalassaemia not being explained by differences in haemoglobin or MCHC. In SS disease, SpO2 levels were not associated with age (within this age range), sex, number of sick clinic visits or number of hospital admissions. Higher SpO2 levels were associated with greater height and weight, more frequent painful crises and less frequent acute chest syndrome, but these associations were not significant after adjustment for haemoglobin level. Desaturation is common in steady-state SS disease and knowledge of the individual's steady-state value may be important in the interpreting low values during acute complications.
Subject(s)
Anemia, Sickle Cell/blood , Anemia, Sickle Cell/metabolism , Oximetry , Adolescent , Age Factors , Cerebrovascular Disorders/blood , Cerebrovascular Disorders/metabolism , Chest Pain/blood , Chest Pain/metabolism , Child , Cohort Studies , Female , Genotype , Growth/physiology , Humans , Intelligence Tests , Male , Oximetry/standards , Oximetry/statistics & numerical data , Oxygen/administration & dosage , Oxygen/blood , Reference Values , Reproducibility of Results , Severity of Illness Index , Sex FactorsABSTRACT
Oxygen saturation was determined by pulse oximetry in a representative sample of Jamaican patients with steady state sickle cell disease in a cohort study from birth. There were 220 with homozygous sickle cell (SS) disease and 142 with sickle cell-haemoglobin C (SC) disease aged 9-18 years, and 122 with a normal haemoglobin (AA) genotype aged 15-18 years. Pulse oximetry (SpO2) values were lower in SS disease (mean [95 percent confidence interval]), 92.5 [92.0-93.3]. Inhalation of 100 percent oxygen in SS patients with 02 saturations below 90 percent consistency increased saturation to 99-100 percent. In SS disease, Sp02 correlated positively with haemoglobin and fetal haemoglobin and negatively with reticulocyte counts but not MCHC, MCV or bilirubin level. Mean Sp02 in SS subjects with a normal alpha globin gene complement (mean[SD], 91.7 [3.9]percent) was lower than in heterozygotes (93.4 [4.0] percent) or homozygotes (96.1 [3.0] percent) for alpha+thalassaemia, the effects of alpha-thalassaemia not being explained by differences in haemoglobin or MCHC. In SS disease, Sp02 levels were not associated with age (within this age range), sex, number of sick clinic visits or number of hospital admissions. Higher Sp02 levels were associated with greater heights and weights, more frequent painful crises and less frequent acute chest syndrome, but these associations were not significant after adjustment for haemoglobin level. Desaturation is common in steady-state SS disease and knowledge of the individual's steady-state value may be important in the interpreting low value during acute complications.(AU)
Subject(s)
Child , Female , Humans , Male , Adolescent , Anemia, Sickle Cell/blood , Anemia, Sickle Cell/metabolism , Oximetry , Age Factors , Cerebrovascular Disorders/blood , Cerebrovascular Disorders/metabolism , Chest Pain/blood , Chest Pain/metabolism , Cohort Studies , Genotype , Growth/physiology , Intelligence Tests , Oximetry/standards , Oximetry/statistics & numerical data , Oxygen/administration & dosage , Oxygen/blood , Reference Values , Severity of Illness Index , Sex Factors , JamaicaABSTRACT
We have studied fibrinogen levels (Clauss technique) in atherothrombotic ischemic stroke patients, in order to determine its role as a thrombogenic risk factor. Twenty nine patients (20 men and 9 women) between 25 and 79 years old were studied; they all have had a atherothrombotic stroke. They were classified into two groups according to the result of their carotid doppler ultrasonography: gl-without carotid flow reduction (n = 19) and g2-with carotid flow reduction (n = 10). The fibrinogen mean value was 269 mg/dl in gl and 353 mg/dl in g2. There were 47% of patients in gl and 80% of patients in g2 who presented levels > 300 mg/dl. The proportions of the groups were significantly different (p < 0.05). Considering the epidemiological value of 300 mg/dl, we conclude that the fibrinogen can be an independent risk factor for ischemic atherothrombotic stroke, specially in those whose carotid flow is reduced.
Subject(s)
Cerebrovascular Disorders/epidemiology , Fibrinogen/analysis , Adult , Aged , Brain Ischemia/blood , Cerebrovascular Disorders/blood , Female , Fibrinogen/physiology , Humans , Intracranial Embolism and Thrombosis/blood , Male , Middle Aged , Risk Factors , Statistics, NonparametricABSTRACT
Oxygen saturation was determined by pulse oximetry in a representative sample of Jamaican patients with steady-state sickle cell disease in a cohort study from birth. There were 220 with homozygous sickle cell (SS) disease and 142 with sickle cell- haemoglobin C (SC) disease aged 9-18 years, and 122 with a normal haemoglobin (AA) genotype aged 15-18 years. Pulse oximetry (SpO2) values were lower in SS disease (mean [95 percent confidence interval], 92.5 [92.0-93.0]) than in SC disease (96.7 [96.9-96.9]) or AA controls (97.1 [96.8-97.3]). Inhalation of 100 percent oxygen in SS patients with O2 saturations below 90 percent consistently increased saturation to 99-100 percent. In SS disease, SpO2 correlated positively with haemoglobin and fetal haemoglobin and negatively with reticulocyte counts but not with MCHC, MCV or bilrubin level. Mean SpO2 in SS subjects with a normal alpha globin gene complement (mean [SD], 91.7 [3.9] percent) was lower than in heterozygotes (93.4 [4.0] percent) or homozygotes (96.1 [3.0] percent) for O+ thalassaemia, the effects of O-thalassaemia not being explained by differences in haemoglobin or MCHC. In SS disease, SpO2 levels were not associated with age (within this age range), sex, number of sick clinic visits or number of hospital admissions. Higher SpO2 levels were associated with greater height and weight, more frequent painful crises and less frequent acute chest syndrome, but these associations were not significant after adjustment for haemoglobin level. Desaturation is common in steady-state SS disease and knowledge of the individual's steady-state value may be important in the interpreting low values during acute complications.(AU)
Subject(s)
Adolescent , Child , Female , Humans , Male , Anemia, Sickle Cell/blood , Anemia, Sickle Cell/metabolism , Oximetry , Cerebrovascular Disorders/blood , Cerebrovascular Disorders/metabolism , Chest Pain/blood , Chest Pain/metabolism , Genotype , Growth/physiology , Intelligence Tests , Oxygen/administration & dosage , Oxygen/blood , Reference Values , Severity of Illness Index , Oximetry/standards , Oximetry/statistics & numerical data , Sex Factors , Age Factors , Cohort StudiesABSTRACT
BACKGROUND AND PURPOSE: Although 4% of cerebral infarcts in the young can be attributed to hematologic disturbances that predispose to thrombosis, the frequency of cerebral infarcts caused by prothrombotic states is not known. Recently, the association between cerebral infarction and deficiencies of elements of the natural anticoagulant system has been recognized. METHODS: Thirty-six consecutive patients under 40 years of age with cerebral infarction of undetermined cause were prospectively studied. Quantitation of natural anticoagulants was done at least 3 months after the cerebral infarction. The following activity tests were performed, all by the chromogenic method: antithrombin III, protein C, plasminogen, tissue plasminogen activator, and inhibitor of tissue plasminogen activator. Protein S was quantified by the Laurell rocket method. All patients underwent a complete cardiological examination, including two-dimensional echocardiography, as well as four-vessel cerebral angiography. Some patients were also studied by transesophageal echocardiography. RESULTS: Of 36 patients, 17 were male, with a mean age of 28 years. Mean age for women was 25 years. Nine patients (25%; 5 women, 4 men) had a deficiency of one natural anticoagulant and constituted group I. In these patients, isolated protein S deficiency was detected in five cases (13.8%); in one case, we observed the association between protein S deficiency and antiphospholipid antibodies; and deficiency of protein C was seen in one case (2.7%), of antithrombin III in one case (2.7%), and of plasminogen in one case (2.7%). Instances of cerebral infarction without natural anticoagulant deficiency (group II) included 12 women and 15 men. There were no differences in clinical and radiological findings between the two groups. CONCLUSIONS: Considering the importance of prothrombotic state, especially caused by deficiency of protein S, in the development of cerebral infarcts, we suggest that it should be looked for in every young patient affected by this pathological entity and in whom no etiologic factors can be determined.
Subject(s)
Antithrombin III/analysis , Cerebral Infarction/blood , Cerebrovascular Disorders/blood , Plasminogen/analysis , Protein C/analysis , Tissue Plasminogen Activator/blood , Adult , Biomarkers/blood , Female , Humans , Male , Prospective Studies , Protein S/bloodABSTRACT
Cerebrovascular accidents (CVA) constitute a major cause of adult cardiac cardiovascular mortality in Chile. From July 87 to August 89 we prospectively studied 300 patients with CVA utilizing a multidisciplinary approach. Besides clinical evaluation this included brain CT scan (48 hrs), glucidic and lipid profile. Occlusive CVA were additionally studied with 2D-Echocardiogram, 24 hr Holter, Cerebral Angiography and/or carotid Duplex Echotomograph, and a second brain CT scan was performed within the first week. We found a 62.3% incidence of cerebral infarcts, 28.3% of cerebral hemorrhages and 9.3% of transient ischemic attacks. Cerebral infarcts were found to be cardiac related in 33.5% of cases, whereas 13.2% were lacunar, 4.4% were atherothrombotic and 14% had no precise etiology. Hypertension was associated to cerebral hemorrhages in 76% of cases, 26% of which were intracranial. At 2 months of follow-up 16.3% of patients were severely handicapped and mortality was 19.3%. We have confirmed that cerebral infarcts constitute the most common cause of CVA and most of them are cardiac related. Hypertension appears to be the most important cause of cerebral hemorrhage. A multidisciplinary approach to cerebrovascular accidents allowed a more precise diagnosis and contributed to implement appropriate therapeutic and preventive strategies. Proper identification of high risk patients could contribute to decrease the high incidence and mortality of CVA in our community.
Subject(s)
Cerebrovascular Disorders/epidemiology , Aged , Cerebrovascular Disorders/blood , Cerebrovascular Disorders/classification , Cerebrovascular Disorders/diagnosis , Chile/epidemiology , Female , Humans , Incidence , Male , Middle Aged , Patient Care Team , Pilot Projects , Prospective Studies , Severity of Illness Index , Tomography, X-Ray ComputedABSTRACT
Se implementa una técnica sencilla para medir la viscosidad sanguínea y plasmática, midiendo el tiempo que demora una cantidad determinada de sangre o plasma en recorrer un segmento de tubo, a temperatura y presión constante. Se analizan 100 muestras de sujetos normales, de acuerdo a parámetros determinados al inicio del estudio. Se concluyen valores expresados en viscosidad relativa similares a los encontrados en viscosímetros por otros autores. Promedio 4,5 u de viscosidad sanguínea para hombres y mujeres, y 1,9 u de viscosidad plasmática en mujeres y hombres, respectivamente. De esto concluimos que no hay diferencias significativas entre viscosidad sanguínea y viscosidad plasmática según sexo, edad, hematocrito normal y el tiempo transcurrido entre la toma de muestra y la medición en laboratorio para el grupo en estudio. Se deja planteada la inquietud de continuar analizando la viscosidad sanguínea de acuerdo a otros parámetros, como diabetes descompensada, accidentes vasculares u otras patologías o cuadros clínicos en que se describen alteraciones de viscosidad sanguínea